Allied Market Research
Allied Market Research

Compounding Pharmacies Market: Global Opportunity Analysis and Industry Forecast, 2020-2030

Pages: NA
Sep 2021 | 62 Views
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Compounding Pharmacies Market: Global Opportunity Analysis and Industry Forecast, 2020-2030

Request Now !

Compounding Pharmacies Market Outlook - 2030

The role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs in the market. Compounded drugs are the amalgamation of two or more drug ingredients in different proportions, i.e., combining or altering the active pharmaceutical ingredients of drugs to meet the unmet medical need of an individual patient. The major driver of compounding pharmacies market is worldwide increasing geriatric population. The population aged 60 or above is growing rapidly thus the demand for anti-aging products which use custom compounded drugs are increasing. Moreover, the ease of administering compounded drugs is particularly distinguished in critical illnesses such as cancer, where a patient is incapable to swallow a pain-reducing drug. The drug is either administered as a transdermal application, lollipop, or sterile preparation.

Report Metric


 Market size available for years


 Base year considered


 Forecast period


 Forecast units

 Value (USD)

 Segments covered

 Product, Therapeutic Type, Compounding Type and Region

 Geographies covered

 North America, Europe, Asia-Pacific, LAMEA

 Companies covered

AmerisourceBergen, Rx3 Pharmacy, Agbi’s Sterile Compounding Pharmacy LLC, B. Braun Medical Inc., Cantrell Drug Company, Inc., Imprimis Pharmaceuticals, Inc., Institutional Pharmacies Of Louisiana LLC, Lorraine's Pharmacy, McGuff Sterile Compounding Pharmacy Services, Inc., Panaceutics Inc., Pencol Compounding Pharmacy, Fagron, ITC Compounding Pharmacy, SCA Pharmaceuticals, Wedgewood Pharmacy, Fresenius Kabi AG, and Dougherty's Holdings, Inc

COVID-19 scenario analysis:

Coronavirus disease 2019 (COVID-19) has created an economic crisis in addition to the healthcare crisis. COVID-19 pandemic has stretched healthcare system worldwide; developed countries are expected to cause economic recession. The pandemic has an adverse impact on the healthcare system, resulting in 50% to 70% drop in revenue from March. Many small hospitals, clinics, and nursing homes, have been forced to shut their operations. In addition, social distancing and localized curfews have resulted in delayed elective surgical procedures. Further, visa cancellations have led to an interruption in medical tourism and can negatively impact the healthcare services market growth.

Pandemics, like other humanitarian crises, are times of great change and uncertainty to overcome this situation hence In response to shortages of medicines needed for Covid-19 patients on ventilators, the Food and Drug Administration is temporarily easing its rules so that compounders can start making some of the drugs for as long as the nationwide public health emergency is in effect, the agency will not take action against compounding pharmacies that make a medicine that is a copy of an approved drug, use bulk ingredients not on an approved list, or fail to meet good manufacturing requirements for stability testing. “In light of unprecedented disruptions to, and demands on, the global pharmaceutical supply chain as a result of the Covid-19 pandemic, and in order to respond to evolving regional conditions, additional flexibility is temporarily needed to ensure that treatment options are available when hospitals are unable to obtain FDA-approved drugs used for hospitalized patients with Covid-19,” the FDA said in a guidance.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

Global Market Analysis:

The global compounding pharmacies market is segmented on the basis of product type which is further divided into oral, topical, mouthwashes, suppositories, injectable, and ophthalmic. The oral product type is further segmented into capsules, tablets, suspension, lozenges, and lollipops. The topical products are further classified into creams, gels, ointments, and lotions. The injectable segment is sub-segmented into injections, infusions, concentrates, powders for reconstitution, and gels. Among which oral product segment dominates the market, owing to the convenience of oral medication, safe, and non-invasive route of administration, which will increase the patient preference for oral medications thus fuelling the growth of oral segment during the forecast period.

Regional Analysis:

North America held a dominant share for the global market for compounding pharmacies in 2017 and region is projected to continue with its regional supremacy in the forthcoming years as well. The growth of this regional market is attributed with the favourable government policies, high acceptance of compounded drugs, and increasing number of compounding pharmacies in the region. Asia Pacific is projected to grow at a significant CAGR due to rising healthcare infrastructure. Moreover, increase in the research & development activities with regards to improvement in the several healthcare outcomes and to obtain more accurate and precise results will propel the growth of the compounding pharmacies market in Asia Pacific region. Increasing incidences of chronic disorders and augmentation in the geriatric population will also increase the burden on the healthcare economy and will drive the market during the forecast period.

Rising demand for personalized medicine is a key factor spurring revenues of U.S. compounding pharmacies. The ‘made from scratch’ factor is one of the key factors enhancing the visibility of compounding pharmacies in the U.S. The medications prepared in compounding pharmacies are prepared by blending of ingredients as per the desired strength and dosage, which makes them ideal for addressing issues of optimal drug usage. The core value, which is developing tailor-made drugs to cater to patients’ needs, is one of the key aspects fostering popularity of U.S. compounding pharmacies.

Pharmaceutical dosage alteration segment will witness a considerable 5.1% CAGR during the forecast period attributable to the surging demand for altered dosage forms to avoid difficulty in swallowing, mask unpalatable taste as well as offer efficient dosage forms to meet individual patient needs.


  • Increasing geriatric population & longevity globally
  • Growing acceptance of personalized medicines worldwide in U.S. and Europe
  • Increasing drug shortage in North America and Europe
  • Convenience of using compounded drugs
  • Growing drug failure rate

Challenges and Restrains:

  • Lack of skilled lab technicians and pharmacists in developed countries
  • High costs of equipment and maintenance of sterile environment
  • Changing regulatory specifications
  • Consumers perception towards compounded drugs

Key Market Players and their roles:

  • Some of the prominent market players operating in compounding pharmacies market include Fagron, PharmaMEDium, B. Braun Medical, Institutional Pharmacy Solutions, Triangle Compounding Pharmacies, Fresenuis Kabi, Lorraine’s Pharmacy, Wedgewood Village Pharmacy, Doughtery’s Pharmacy, Village compounding Pharmacies, Mcguff compounding pharmacy services, Rx3 Compounding Pharmacy, Pencol Compounding Pharmacy, ITC Compounding Pharmacy. These eminent industry players strategically execute various in-organic growth strategies such as mergers and acquisitions to sustain market competition.
  • In July 2015, Fagron announced the acquisition of JCB labs with the goal to redesign the United States’ sterile compounding industry. This acquisition was envisioned with an aim for Fagron to become the high-quality sterile compounding manufacturer in North America.
  • In April 2017, Fresenius Kabi acquired Merck KGaA and Akorn’s biosimilars business. This acquisition was envisioned with an aim to diversify and strengthen Fresenius Kabi’s product portfolio




By Therapeutic Area:



  • Hormone Replacement
  • Pain Management
  • Dermatology applications
  • Specialty drugs
  • Nutritional supplements
  • Other

By product:


  1. Solid preparations
  • Tablets
  • Capsules
  • Granules
  • Powder
  1. Liquid preparations
  • Solutions
  • Suspension
  • Emulsion
  • Syrup
  1. Topical
  • Ointments
  • Creams
  • Gels
  • Pastes
  1. Rectal
  • Suppositories
  • Enema
  1. Parenteral
  • LVP
  • SVP
  1. Nasal
  • Ophthalmic
  • Otic


By Compounding type:


  • Pharmaceutical Ingredient Alteration (PIA)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM)
  • Pharmaceutical Dosage Alteration (PDA)
  • Others


Key benefits of the report:

  • This study presents the analytical depiction of the global compounding pharmacies market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global compounding pharmacies market share.
  • The current market is quantitatively analyzed from 2021 to 2030 to highlight the global compounding pharmacies market growth scenario.
  • The report provides a detailed global compounding pharmacies market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Thermistor Market research report:

  • What are the leading market players active in the compounding pharmacy market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?


With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at

Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.











Purchase Full Report of
Compounding Pharmacies Market: Global Opportunity Analysis and Industry Forecast, 2020-2030

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $8,995  $8,096
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading.
    This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Reports


Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings


Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers